Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PPP1R14D (Protein phosphatase 1 regulatory inhibitor subunit 14D) is a regulatory protein that inhibits protein phosphatase 1 (PP1) when phosphorylated, serving as a molecular switch for the regulation of PP1 activity. By controlling the reversible phosphorylation of serine/threonine residues, PPP1R14D modulates essential signal transduction pathways. It is found with highest expression in the gastrointestinal tract and brain (hence, some aliases), and is notably upregulated in lung adenocarcinoma, where it drives cancer cell proliferation, migration, and invasion via the PKCα/BRAF/MEK/ERK signaling pathway. Dysregulation links PPP1R14D with poor cancer prognosis, identifying it as a potential biomarker and therapeutic target. PPP1R14D belongs to the family of protein phosphatase 1 regulatory subunits, and its function depends on phosphorylation events, primarily by PKC, making it an important nexus in phosphorylation-dependent cellular control[1][2][5].
Drugs or agents that modulate PPP1R14D likely act by modifying its phosphorylation state, thus altering its inhibitory effect on PP1 activity and downstream signaling pathways[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein phosphatase 1 regulatory inhibitor subunit 14D (PPP1R14D).